Book an appointment
Call (678) 846-2000
Contact Us/Text Us
Low-Dose Atropine Eye Drops
Evidence-guided low-dose atropine for childhood myopia management in Decatur & Atlanta
Help Slow Your Child’s Worsening Nearsightedness
If your child’s glasses prescription keeps getting stronger, correcting today’s blur may not be enough. Myopia—also called nearsightedness—often progresses as a child’s eye grows longer. Greater myopia is associated with a higher lifetime risk of retinal detachment, myopic macular disease, glaucoma, and cataracts.
At Specs Appeal in Decatur, we look beyond the current prescription. We evaluate how quickly your child’s myopia is changing, discuss the evidence and its limitations, and build a plan around your child—not around a single product.
Prefer to text or call? 678-846-2000
What Is Low-Dose Atropine?
Low-dose atropine is a prescription eye drop used once daily—often at bedtime—to help slow myopia progression in some children. The goal is not to reverse myopia or eliminate glasses. It is to reduce the rate of change while a child’s eyes are still growing.
The treatment uses much lower concentrations than the 1% atropine commonly used to dilate the eyes. Lower concentrations are intended to preserve benefit while reducing light sensitivity and near blur.
The American Association for Pediatric Ophthalmology and Strabismus recognizes low-dose atropine as one of the approaches used to slow progressive childhood myopia.
Who May Be a Candidate?
A myopia evaluation may be appropriate if your child:
Has a glasses prescription that is becoming more nearsighted
Developed myopia at a young age
Has one or two nearsighted parents
Is progressing despite standard glasses or contact lenses
Needs a non-contact-lens option for myopia management
Low-dose atropine is not right for every child. A complete examination and an accurate progression history are needed before treatment.
What to Expect at Specs Appeal
1. Establish a reliable baseline
We review previous prescriptions and eye-health history, assess current vision and refraction, and evaluate the health of the eyes. We also measure axial length—the front-to-back length of the eye—to help monitor structural growth over time.
2. Compare the appropriate options
We explain whether atropine, a myopia-control contact lens, an overnight lens, a specialty spectacle lens, or a combined approach deserves consideration. Explore our myopia-control options.
3. Create a practical treatment plan
If atropine is appropriate, we prescribe the concentration selected for your child and teach you how to use and store the drops. We coordinate prescriptions through a carefully selected compounding pharmacy.
4. Monitor response—not just visual acuity
Follow-up matters. At scheduled visits, we compare meaningful changes and assess comfort, adherence, and side effects. If progression continues, we revisit the dose, delivery, or overall strategy.
Have your child’s last two prescriptions?
Bring them to the visit so we can evaluate the rate of change.
Is Low-Dose Atropine Effective?
Research supports atropine as a myopia-management option, but the response varies by child, concentration, formulation, and study population.
The randomized LAMP study found that 0.05%, 0.025%, and 0.01% atropine slowed myopia progression over one year, with 0.05% producing the strongest overall effect.
The three-year CHAMP trial, conducted in North America and Europe, found benefit with a preservative-free 0.01% formulation on its principal efficacy measures; 0.02% did not meet the trial’s primary responder endpoint.
An NIH-funded U.S. trial found that a different 0.01% preparation did not outperform placebo over two years.
That is why we do not treat “low-dose atropine” as one universal protocol. We consider age, prescription history, family history, examination findings, lifestyle, prior treatment, and how the eyes respond over time before recommending a concentration or changing the plan. This is managed in a myopia management treatment plan.
Our approach at Specs Appeal: Measure. Personalize. Monitor. Adjust.
Safety and Side Effects
Low-dose atropine is generally well tolerated in clinical studies. Possible effects include temporary stinging, light sensitivity, larger pupils, near blur, redness, or an allergic reaction. Side effects may vary with concentration and formulation. Contact our office if your child develops persistent discomfort, significant redness or swelling, or a change in vision.
In the United States, low-dose atropine for slowing childhood myopia is currently prescribed off-label and is generally prepared by a compounding pharmacy. “Off-label” means the medication is being used for a purpose that does not yet have FDA approval; it does not mean the treatment is experimental or inappropriate. As of August 2026, the FDA is reviewing a proprietary low-dose atropine formulation, but there is not yet an FDA-approved atropine reference product for pediatric myopia management. Read the AAPOS statement on the FDA review.
Frequently Asked Questions
Will low-dose atropine cure my child’s myopia?
No. It is intended to slow progression, not reverse myopia. Your child will still need glasses or contact lenses for clear vision.
What strength of atropine is best?
There is no single best concentration for every child. Studies have examined concentrations including 0.01%, 0.025%, and 0.05%, with different results. We select a starting approach based on your child’s risk, progression, tolerance, and the current evidence, then monitor the response.
How often are the drops used?
Low-dose atropine is commonly prescribed as one drop in each eye at bedtime. Follow the instructions written for your child; do not use another person’s drops or change the dose without speaking with the prescribing clinician.
How long will my child need treatment?
Treatment often continues through the years when myopia is actively progressing. The exact duration and the decision to taper or stop depend on age, stability, response, and the clinician’s judgment. Continued follow-up is important because progression can resume after treatment ends.
Can atropine be combined with glasses or contact lenses?
Yes. Atropine does not provide clear distance vision, so glasses or contact lenses are still needed. For some children, the care plan may combine atropine with an optical myopia-control glasses like Stellest.
How soon will we know if it is working?
Myopia control is judged over time, not by how the eyes feel the next morning. We compare follow-up measurements with a reliable baseline and look for a slower rate of change. No treatment can guarantee that progression will stop completely.
Do you see families from outside Atlanta?
Yes. Specs Appeal welcomes families from Atlanta and surrounding communities, including Buckhead, Sandy Springs, Brookhaven, Marietta, or Alpharetta. We will explain the anticipated follow-up schedule so you can plan visits confidently.
A Thoughtful Next Step for Your Child’s Vision
You do not need to choose a treatment before the visit. Bring your questions and, if available, your child’s earlier prescriptions. We will determine whether the myopia is progressing, explain the options in plain language, and recommend a plan you can understand and sustain.
This page is for general education and does not replace an eye examination or individualized medical advice. Treatment recommendations require an evaluation by a qualified eye-care professional.